Compare AANJANEYA LIFECARE with Dishman Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs DISHMAN PHARMA - Comparison Results

DISHMAN PHARMA 
   Change

Dishman Pharmaceuticals is involved in the manufacture of APIs (active pharmaceutical ingredients), intermediates, quaternary compounds and fine chemicals. Besides this, the company is a significant player in the CRAMS (Contract Research and Manufact... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. DATSONS LABS DISHMAN PHARMA DR. DATSONS LABS/
DISHMAN PHARMA
 
P/E (TTM) x -10.9 25.1 - View Chart
P/BV x 0.2 3.3 4.9% View Chart
Dividend Yield % 0.0 0.7 -  

Financials

 DR. DATSONS LABS   DISHMAN PHARMA
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
DISHMAN PHARMA
Mar-16
DR. DATSONS LABS/
DISHMAN PHARMA
5-Yr Chart
Click to enlarge
High Rs126374 33.5%   
Low Rs31129 24.0%   
Sales per share (Unadj.) Rs133.0197.8 67.2%  
Earnings per share (Unadj.) Rs0.221.2 0.7%  
Cash flow per share (Unadj.) Rs6.634.7 19.0%  
Dividends per share (Unadj.) Rs02.00 0.0%  
Dividend yield (eoy) %00.8 0.0%  
Book value per share (Unadj.) Rs128.8179.9 71.6%  
Shares outstanding (eoy) m31.6680.69 39.2%   
Bonus/Rights/Conversions FCCB--  
Price / Sales ratio x0.61.3 46.2%   
Avg P/E ratio x516.111.9 4,349.2%  
P/CF ratio (eoy) x11.87.2 163.4%  
Price / Book Value ratio x0.61.4 43.4%  
Dividend payout %09.4 0.0%   
Avg Mkt Cap Rs m2,47720,306 12.2%   
No. of employees `000NA0.8 0.0%   
Total wages/salary Rs m565,355 1.0%   
Avg. sales/employee Rs ThNM19,252.7-  
Avg. wages/employee Rs ThNM6,459.5-  
Avg. net profit/employee Rs ThNM2,064.1-  
INCOME DATA
Net Sales Rs m4,21115,961 26.4%  
Other income Rs m79265 29.7%   
Total revenues Rs m4,28916,226 26.4%   
Gross profit Rs m5694,103 13.9%  
Depreciation Rs m2041,091 18.7%   
Interest Rs m430944 45.6%   
Profit before tax Rs m132,334 0.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m-21 -163.6%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6624 1.0%   
Profit after tax Rs m51,711 0.3%  
Gross profit margin %13.525.7 52.5%  
Effective tax rate %48.026.7 179.7%   
Net profit margin %0.110.7 1.1%  
BALANCE SHEET DATA
Current assets Rs m6,85211,018 62.2%   
Current liabilities Rs m6,7119,517 70.5%   
Net working cap to sales %3.39.4 35.6%  
Current ratio x1.01.2 88.2%  
Inventory Days Days161110 145.6%  
Debtors Days Days31835 914.2%  
Net fixed assets Rs m3,67316,304 22.5%   
Share capital Rs m317161 196.2%   
"Free" reserves Rs m3,76112,907 29.1%   
Net worth Rs m4,07814,516 28.1%   
Long term debt Rs m1,6714,189 39.9%   
Total assets Rs m12,63329,805 42.4%  
Interest coverage x1.03.5 29.7%   
Debt to equity ratio x0.40.3 142.0%  
Sales to assets ratio x0.30.5 62.2%   
Return on assets %3.48.9 38.6%  
Return on equity %0.111.8 1.0%  
Return on capital %7.717.5 43.8%  
Exports to sales %22.924.8 92.4%   
Imports to sales %14.33.7 382.6%   
Exports (fob) Rs m9643,956 24.4%   
Imports (cif) Rs m602596 100.9%   
Fx inflow Rs m9644,952 19.5%   
Fx outflow Rs m607697 87.1%   
Net fx Rs m3574,255 8.4%   
CASH FLOW
From Operations Rs m1,3452,786 48.3%  
From Investments Rs m-2,256-1,529 147.5%  
From Financial Activity Rs m-1,200-941 127.5%  
Net Cashflow Rs m-2,111316 -667.1%  

Share Holding

Indian Promoters % 4.5 61.4 7.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 3.7 -  
FIIs % 1.4 12.7 10.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 94.1 22.1 425.8%  
Shareholders   20,807 46,261 45.0%  
Pledged promoter(s) holding % 0.0 35.8 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. DATSONS LABS With:   FULFORD INDIA  VENUS REMEDIES  STERLING BIOTECH  WOCKHARDT  SUVEN LIFESCIENCES  

Compare DR. DATSONS LABS With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

WPI Inflation Data, Global Stock Market Drivers, and Top Cues in Focus Today(Pre-Open)

On Monday, Indian share markets witnessed negative trading activity throughout the day and ended lower.

Related Views on News

MSTC IPO: Should You Bet on This State-Run E-Commerce Player? (IPO)

Mar 13, 2019

Should you subscribe to the IPO of MSPC Limited?

MSTC IPO: Should You Bet on This State-Run E-Commerce Player? (IPO)

Mar 13, 2019

Should you subscribe to the IPO of MSPC Limited?

Hindustan Aeronautics IPO: Yet Another Play on India's Defence Sector (IPO)

Mar 14, 2018

Should you apply for the IPO of state-run military aircraft maker Hindustan Aeronautics?

Bharat Dynamics IPO: Worth Betting on Defence Manufacturing? (IPO)

Mar 12, 2018

Should you apply for the IPO of Bharat Dynamics, India's first state-owned missile manufacturer?

Apollo Micro Systems Ltd. (IPO)

Jan 9, 2018

Should you subscribe to the IPO of Apollo Micro Systems Ltd?

More Views on News

Most Popular

Buying these Eight Stocks is Like Owning Your Own Business(Profit Hunter)

Sep 5, 2019

Everyone dreams of owning a business. Here is your chance.

7 Stocks to Buy in the Market Today(The 5 Minute Wrapup)

Sep 5, 2019

The stock market had a four-year bull run starting September 2013. Are we seeing a similar pattern now?

Don't Buy Lakshmi Vilas Bank...Buy this Private Sector Bank with 74% Upside(The 5 Minute Wrapup)

Sep 4, 2019

Lakshmi Vilas Bank is in a vicious cycle. The stock is already down 57% in 2019. Despite this, the retail investors increased their holding.

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

A Recession Proof Stock You Can Bet On(Profit Hunter)

Sep 10, 2019

Usually, the typical horizon period for my smallcap recommendations is 3 to 5 years. But if you ask me, this could be one business that you could own and pass on to future generations.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS 8-QTR ANALYSIS

COMPARE DR. DATSONS LABS WITH

MARKET STATS